Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 81

    1.

    DreamTel; Diabetes risk evaluation and management tele-monitoring study protocol.

    Tobe SW, Wentworth J, Ironstand L, Hartman S, Hoppe J, Whiting J, Kennedy J, McAllister C, Kiss A, Perkins N, Vincent L, Pylypchuk G, Lewanczuk RZ.

    BMC Endocr Disord. 2009 May 9;9:13.PMID: 19426530 [PubMed - in process]Related articlesFree article

    2.

    The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2--therapy.

    Khan NA, Hemmelgarn B, Herman RJ, Bell CM, Mahon JL, Leiter LA, Rabkin SW, Hill MD, Padwal R, Touyz RM, Larochelle P, Feldman RD, Schiffrin EL, Campbell NR, Moe G, Prasad R, Arnold MO, Campbell TS, Milot A, Stone JA, Jones C, Ogilvie RI, Hamet P, Fodor G, Carruthers G, Burns KD, Ruzicka M, DeChamplain J, Pylypchuk G, Petrella R, Boulanger JM, Trudeau L, Hegele RA, Woo V, McFarlane P, Vallée M, Howlett J, Bacon SL, Lindsay P, Gilbert RE, Lewanczuk RZ, Tobe S; Canadian Hypertension Education Program.

    Can J Cardiol. 2009 May;25(5):287-98. Review.PMID: 19417859 [PubMed - indexed for MEDLINE]Related articles

    3.

    2009 Canadian Hypertension Education Program recommendations: the scientific summary--an annual update.

    Campbell NR, Khan NA, Hill MD, Tremblay G, Lebel M, Kaczorowski J, McAlister FA, Lewanczuk RZ, Tobe S; Canadian Hypertension Education Program.

    Can J Cardiol. 2009 May;25(5):271-7. Review.PMID: 19417857 [PubMed - indexed for MEDLINE]Related articles

    4.

    Cardiorespiratory fitness and the risk of overweight in youth: the Healthy Hearts Longitudinal Study of Cardiometabolic Health.

    McGavock JM, Torrance BD, McGuire KA, Wozny PD, Lewanczuk RZ.

    Obesity (Silver Spring). 2009 Sep;17(9):1802-7. Epub 2009 Mar 12.PMID: 19282826 [PubMed - indexed for MEDLINE]Related articles

    5.

    Influence of controlled rheumatoid arthritis on the action and disposition of verapamil: focus on infliximab.

    Ling S, Lewanczuk RZ, Russell AS, Ihejirika B, Jamali F.

    J Clin Pharmacol. 2009 Mar;49(3):301-11. Epub 2009 Jan 23.PMID: 19168802 [PubMed - indexed for MEDLINE]Related articles

    6.

    Tackling the burden of hypertension in Canada: encouraging collaborative care.

    Thompson A, Campbell NR, Cloutier L, Costello JA, Dawes M, Hickey J, Kaczorowski J, Lewanczuk RZ, Semchuk W, Tsuyuki RT; Canadian Hypertension Education Program Implementation Task Force.

    Can Fam Physician. 2008 Dec;54(12):1659-62, 1664-7. Review. English, French. No abstract available. PMID: 19074693 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Enhancing hypertension awareness and management in the elderly: lessons learned from the Airdrie Community Hypertension Awareness and Management Program (A-CHAMP).

    Jones C, Simpson SH, Mitchell D, Haggarty S, Campbell N, Then K, Lewanczuk RZ, Sebaldt RJ, Farrell B, Dolovitch L, Kaczorowski J, Chambers LW.

    Can J Cardiol. 2008 Jul;24(7):561-7.PMID: 18612498 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Pericarditis with cardiac tamponade and addisonian crisis as the presenting features of autoimmune polyglandular syndrome type II: a case series.

    Alkaabi JM, Chik CL, Lewanczuk RZ.

    Endocr Pract. 2008 May-Jun;14(4):474-8.PMID: 18558603 [PubMed - indexed for MEDLINE]Related articles

    9.

    The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.

    Khan NA, Hemmelgarn B, Herman RJ, Rabkin SW, McAlister FA, Bell CM, Touyz RM, Padwal R, Leiter LA, Mahon JL, Hill MD, Larochelle P, Feldman RD, Schiffrin EL, Campbell NR, Arnold MO, Moe G, Campbell TS, Milot A, Stone JA, Jones C, Ogilvie RI, Hamet P, Fodor G, Carruthers G, Burns KD, Ruzicka M, dechamplain J, Pylypchuk G, Petrella R, Boulanger JM, Trudeau L, Hegele RA, Woo V, McFarlane P, Vallée M, Howlett J, Katzmarzyk P, Tobe S, Lewanczuk RZ; Canadian Hypertension Education Program.

    Can J Cardiol. 2008 Jun;24(6):465-75. Review.PMID: 18548143 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Acute effect of metformin on exercise capacity in active males.

    Johnson ST, Robert C, Bell GJ, Bell RC, Lewanczuk RZ, Boulé NG.

    Diabetes Obes Metab. 2008 Sep;10(9):747-54. Epub 2007 Oct 26.PMID: 17970761 [PubMed - indexed for MEDLINE]Related articles

    11.

    The relationship between weight gain and blood pressure in children and adolescents.

    McGavock JM, Torrance B, McGuire KA, Wozny P, Lewanczuk RZ.

    Am J Hypertens. 2007 Oct;20(10):1038-44.PMID: 17903685 [PubMed - indexed for MEDLINE]Related articles

    12.

    The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.

    Khan NA, Hemmelgarn B, Padwal R, Larochelle P, Mahon JL, Lewanczuk RZ, McAlister FA, Rabkin SW, Hill MD, Feldman RD, Schiffrin EL, Campbell NR, Logan AG, Arnold M, Moe G, Campbell TS, Milot A, Stone JA, Jones C, Leiter LA, Ogilvie RI, Herman RJ, Hamet P, Fodor G, Carruthers G, Culleton B, Burns KD, Ruzicka M, deChamplain J, Pylypchuk G, Gledhill N, Petrella R, Boulanger JM, Trudeau L, Hegele RA, Woo V, McFarlane P, Touyz RM, Tobe SW; Canadian Hypertension Education Program.

    Can J Cardiol. 2007 May 15;23(7):539-50.PMID: 17534460 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    The natural history of LDL control in type 2 diabetes: a prospective study of adherence to lipid guidelines.

    Rucker D, Johnson JA, Lee TK, Eurich DT, Lewanczuk RZ, Simpson SH, Toth EL, Majumdar SR.

    Diabetes Care. 2006 Nov;29(11):2506-8. No abstract available. PMID: 17065693 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Drug-disease interactions: losartan effect is not downregulated by rheumatoid arthritis.

    Daneshtalab N, Lewanczuk RZ, Russell AS, Jamali F.

    J Clin Pharmacol. 2006 Nov;46(11):1344-55.PMID: 17050800 [PubMed - indexed for MEDLINE]Related articles

    15.

    Impaired arterial compliance and aerobic endurance in kidney transplant recipients.

    Riess KJ, Gourishankar S, Oreopoulos A, Jones LW, McGavock JM, Lewanczuk RZ, Haykowsky MJ.

    Transplantation. 2006 Oct 15;82(7):920-3.PMID: 17038907 [PubMed - indexed for MEDLINE]Related articles

    16.

    Sedentary lifestyle and antecedents of cardiovascular disease in young adults.

    McGavock JM, Anderson TJ, Lewanczuk RZ.

    Am J Hypertens. 2006 Jul;19(7):701-7.PMID: 16814124 [PubMed - indexed for MEDLINE]Related articles

    17.

    The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II - Therapy.

    Khan NA, McAlister FA, Rabkin SW, Padwal R, Feldman RD, Campbell NR, Leiter LA, Lewanczuk RZ, Schiffrin EL, Hill MD, Arnold M, Moe G, Campbell TS, Herbert C, Milot A, Stone JA, Burgess E, Hemmelgarn B, Jones C, Larochelle P, Ogilvie RI, Houlden R, Herman RJ, Hamet P, Fodor G, Carruthers G, Culleton B, Dechamplain J, Pylypchuk G, Logan AG, Gledhill N, Petrella R, Tobe S, Touyz RM; Canadian Hypertension Education Program.

    Can J Cardiol. 2006 May 15;22(7):583-93.PMID: 16755313 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Applying the 2005 Canadian Hypertension Education Program recommendations: 4. Managing uncomplicated hypertension.

    Khan NA, Hamet P, Lewanczuk RZ; Canadian Hypertension Education Program.

    CMAJ. 2005 Oct 11;173(8):865-7. No abstract available. PMID: 16217106 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Arterial compliance in young children: the role of aerobic fitness.

    Reed KE, Warburton DE, Lewanczuk RZ, Haykowsky MJ, Scott JM, Whitney CL, McGavock JM, McKay HA.

    Eur J Cardiovasc Prev Rehabil. 2005 Oct;12(5):492-7.PMID: 16210937 [PubMed - indexed for MEDLINE]Related articles

    20.

    The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy.

    Khan NA, McAlister FA, Lewanczuk RZ, Touyz RM, Padwal R, Rabkin SW, Leiter LA, Lebel M, Herbert C, Schiffrin EL, Herman RJ, Hamet P, Fodor G, Carruthers G, Culleton B, DeChamplain J, Pylypchuk G, Logan AG, Gledhill N, Petrella R, Campbell NR, Arnold M, Moe G, Hill MD, Jones C, Larochelle P, Ogilvie RI, Tobe S, Houlden R, Burgess E, Feldman RD; Canadian Hypertension Education Program.

    Can J Cardiol. 2005 Jun;21(8):657-72.PMID: 16003449 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Generalizability and persistence of a multifaceted intervention for improving quality of care for rural patients with type 2 diabetes.

    Johnson JA, Eurich DT, Toth EL, Lewanczuk RZ, Lee TK, Majumdar SR.

    Diabetes Care. 2005 Apr;28(4):783-8.PMID: 15793173 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Trends in bariatric surgery in Canada, 1993-2003.

    Padwal RS, Lewanczuk RZ.

    CMAJ. 2005 Mar 15;172(6):735. No abstract available. Erratum in: CMAJ. 2005 Apr 26;172(9):1164. PMID: 15767602 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition.

    Leiter LA, Lewanczuk RZ.

    Am J Hypertens. 2005 Jan;18(1):121-8. Review.PMID: 15691626 [PubMed - indexed for MEDLINE]Related articles

    24.

    Treatment gaps for hypertension management in rural Canadian patients with type 2 diabetes mellitus.

    Supina AL, Guirguis LM, Majumdar SR, Lewanczuk RZ, Lee TK, Toth EL, Johnson JA.

    Clin Ther. 2004 Apr;26(4):598-606.PMID: 15189757 [PubMed - indexed for MEDLINE]Related articles

    25.

    Improvements in patient-reported outcomes associated with an intervention to enhance quality of care for rural patients with type 2 diabetes: results of a controlled trial.

    Maddigan SL, Majumdar SR, Guirguis LM, Lewanczuk RZ, Lee TK, Toth EL, Johnson JA.

    Diabetes Care. 2004 Jun;27(6):1306-12.PMID: 15161780 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Underuse of aspirin in type 2 diabetes mellitus: prevalence and correlates of therapy in rural Canada.

    Klinke JA, Johnson JA, Guirguis LM, Toth EL, Lee TK, Lewanczuk RZ, Majumdar SR.

    Clin Ther. 2004 Mar;26(3):439-46.PMID: 15110137 [PubMed - indexed for MEDLINE]Related articles

    27.

    Rheumatoid arthritis does not reduce the pharmacodynamic response to valsartan.

    Daneshtalab N, Lewanczuk RZ, Russell A, Jamali F.

    J Clin Pharmacol. 2004 Mar;44(3):245-52.PMID: 14973301 [PubMed - indexed for MEDLINE]Related articles

    28.

    Comparison of the [13C]glucose breath test to the hyperinsulinemic-euglycemic clamp when determining insulin resistance.

    Lewanczuk RZ, Paty BW, Toth EL.

    Diabetes Care. 2004 Feb;27(2):441-7.PMID: 14747226 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Low cardiorespiratory fitness is associated with elevated C-reactive protein levels in women with type 2 diabetes.

    McGavock JM, Mandic S, Vonder Muhll I, Lewanczuk RZ, Quinney HA, Taylor DA, Welsh RC, Haykowsky M.

    Diabetes Care. 2004 Feb;27(2):320-5.PMID: 14747207 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Controlled trial of a multifaceted intervention for improving quality of care for rural patients with type 2 diabetes.

    Majumdar SR, Guirguis LM, Toth EL, Lewanczuk RZ, Lee TK, Johnson JA.

    Diabetes Care. 2003 Nov;26(11):3061-6.PMID: 14578240 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Generation, characterization, and use of monoclonal antibodies against parathyroid hypertensive factor.

    Krylova S, Labedz T, Lewanczuk RZ, Benishin CG.

    Clin Chem. 2003 Jul;49(7):1204-6. No abstract available. PMID: 12816926 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Compliance with clinical practice guidelines for type 2 diabetes in rural patients: treatment gaps and opportunities for improvement.

    Toth EL, Majumdar SR, Guirguis LM, Lewanczuk RZ, Lee TK, Johnson JA.

    Pharmacotherapy. 2003 May;23(5):659-65.PMID: 12741441 [PubMed - indexed for MEDLINE]Related articles

    33.

    High-performance liquid chromatographic analysis of angiotensin II receptor antagonist valsartan using a liquid extraction method.

    Daneshtalab N, Lewanczuk RZ, Jamali F.

    J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Jan 25;766(2):345-9.PMID: 11824822 [PubMed - indexed for MEDLINE]Related articles

    34.

    Effect of testosterone on intracellular Ca++ in vascular smooth muscle cells.

    Barbagallo M, Dominguez LJ, Licata G, Ruggero R, Lewanczuk RZ, Pang PK, Resnick LM.

    Am J Hypertens. 2001 Dec;14(12):1273-5. No abstract available. PMID: 11775138 [PubMed - indexed for MEDLINE]Related articles

    35.

    Vascular compliance is reduced in the early stages of type 1 diabetes.

    Romney JS, Lewanczuk RZ.

    Diabetes Care. 2001 Dec;24(12):2102-6.PMID: 11723091 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Hyperplacentosis: a novel cause of hyperthyroidism.

    Ginsberg J, Lewanczuk RZ, Honore LH.

    Thyroid. 2001 Apr;11(4):393-6.PMID: 11349840 [PubMed - indexed for MEDLINE]Related articles

    37.

    Quantitative determination of parathyroid hypertensive factor by enzyme-linked immunosorbent assay.

    Krylova SM, Pang PK, Shan J, Lewanczuk RZ, Benishin CG.

    Am J Hypertens. 2000 Nov;13(11):1173-9.PMID: 11078177 [PubMed - indexed for MEDLINE]Related articles

    38.

    The effect of valsartan and captopril on lipid parameters in patients with type II diabetes mellitus and nephropathy.

    Cheung R, Lewanczuk RZ, Rodger NW, Huff MW, Oddou-Stock P, Botteri F, Pecher E, Muirhead N.

    Int J Clin Pract. 1999 Dec;53(8):584-92.PMID: 10692751 [PubMed - indexed for MEDLINE]Related articles

    39.

    Parathyroid hypertensive factor secretion from subcultured spontaneously hypertensive rat parathyroid cells.

    Benishin CG, Lewanczuk RZ, Shan JJ, Pang PK.

    Am J Hypertens. 1999 Dec;12(12 Pt 1-2):1260-3.PMID: 10619591 [PubMed - indexed for MEDLINE]Related articles

    40.

    Primary hyperaldosteronism and adrenal incidentaloma: an argument for physiologic testing before adrenalectomy.

    McAlister FA, Lewanczuk RZ.

    Can J Surg. 1998 Aug;41(4):299-305.PMID: 9711163 [PubMed - indexed for MEDLINE]Related articles

    41.

    Contemporary practice patterns in the management of newly diagnosed hypertension.

    McAlister FA, Teo KK, Lewanczuk RZ, Wells G, Montague TJ.

    CMAJ. 1997 Jul 1;157(1):23-30.PMID: 9220938 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Parathyroid hypertensive factor and intracellular calcium regulation.

    Pang PK, Shan JJ, Lewanczuk RZ, Benishin CG.

    J Hypertens. 1996 Sep;14(9):1053-60. Review. No abstract available. PMID: 8986903 [PubMed - indexed for MEDLINE]Related articles

    43.

    Resistant hypertension: an overview.

    McAlister FA, Lewanczuk RZ, Teo KK.

    Can J Cardiol. 1996 Sep;12(9):822-8. Review.PMID: 8842136 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    Parathyroid hypertensive factor predicts efficacy in the treatment of essential hypertension with verapamil.

    Lewanczuk RZ, Hamilton PG.

    Blood Press. 1996 Mar;5(2):98-104.PMID: 8860098 [PubMed - indexed for MEDLINE]Related articles

    45.

    Pregnancy-induced Cushing's syndrome in multiple pregnancies.

    Wallace C, Toth EL, Lewanczuk RZ, Siminoski K.

    J Clin Endocrinol Metab. 1996 Jan;81(1):15-21. No abstract available. PMID: 8550743 [PubMed - indexed for MEDLINE]Related articles

    47.

    Protein binding of sotalol enantiomers in young and elderly human and rat serum using ultrafiltration.

    Carr RA, Pasutto FM, Lewanczuk RZ, Foster RT.

    Biopharm Drug Dispos. 1995 Nov;16(8):705-12.PMID: 8573689 [PubMed - indexed for MEDLINE]Related articles

    48.

    PHF: the new parathyroid hypertensive factor.

    Pang PK, Benishin CG, Shan J, Lewanczuk RZ.

    Blood Press. 1994 May;3(3):148-55. Review.PMID: 8069402 [PubMed - indexed for MEDLINE]Related articles

    49.

    Clinical aspects of parathyroid hypertensive factor.

    Lewanczuk RZ, Resnick LM, Ho MS, Benishin CG, Shan J, Pang PK.

    J Hypertens Suppl. 1994 Jan;12(1):S11-6. Review.PMID: 8207559 [PubMed - indexed for MEDLINE]Related articles

    50.

    Purification and structural characterization of parathyroid hypertensive factor.

    Benishin CG, Lewanczuk RZ, Shan J, Pang PK.

    J Cardiovasc Pharmacol. 1994;23 Suppl 2:S9-13.PMID: 7518547 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...